Global Polymerase Chain Reaction Market 2016-2020
PCR as a molecular genetics technique is used to amplify and analyze nucleic acids. It is a very precise, specific, and accurate technique that can amplify a specific DNA target from a mixture of DNA molecules. The technique is prevalently used in a broad range of applications in research and diagnosis including genetic engineering, cloning, genotyping, sequencing, and disease diagnosis.
Technavio’s analysts forecast the global polymerase chain reaction (PCR) market to grow at a CAGR of 8.31% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global polymerase chain reaction (PCR) market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of the PCR consumables, and PCR instruments.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Polymerase Chain Reaction (PCR) Market 2016-2020
Technavio recognizes the following companies as the key players in the global polymerase chain reaction (PCR) market: Agilent Technologies, Agilent Technologies, QIAGEN, Roche Diagnostics, Thermo Fisher Scientific, Beckman Coulter, Becton, Dickinson and Company, bioMérieux, Cepheid, Takara Bio, Eppendorf, Fluidigm, GE Healthcare, Harvard Bioscience, Kapa Biosystems, Maxim Biotech, PerkinElmer, Promega, RainDance Technologies, and Siemens Healthcare.
Commenting on the report, an analyst from Technavio’s team said: “Increasing number of M&A will be a key trend for market growth. M&As are intended to increase the global presence of vendors, expanding product portfolios and helping to attain economies of scale. Thermo Fisher Scientific acquired Life Technologies (a leading provider of life technology products) in February 2014. This acquisition is intended to strengthen Thermos Fisher's presence in life sciences, research, specialty diagnostics, and applied markets. Agilent Technologies acquired Dao in July 2012 and Accretion Technologies in February 2012.”
According to the report, rise in elderly population will be a key driver for market growth. Globally there has been a rise in the number of people above the age of 60 years. The elderly population has tripled from 200 million in 1950 to over 600 million in 2000. The senior citizen segment constitutes a major portion of the population in the developed and developing countries. The elderly population in countries such as the US, South Korea, China, Japan, Italy, Russia, Australia, Germany, Taiwan and Canada, Poland, and Ukraine is increasing. With the rise in chronic illnesses such as diabetes, arthritis, cancer, obesity, heart diseases, and asthma reported in the elderly population in North America and Western Europe, the need for advanced treatment is increasing considerably.
Further, the report states that PCR instruments are often complex and require sophisticated software for various measurement procedures. Skilled handling becomes more important with technological advances in qPCR and dPCR, which are widely used by researchers in various applications such as genotyping, genomics and proteomics, copy number variation (CNV) detection, and gene expression. To operate the instruments and analyze a sample, the user must have a significant level of training with not only the method and the instrument but also the software required to run the analysis and collect the data. End-users need to invest heavily in providing training to their employees to use PCR solutions effectively. The limited number of such trained professionals especially in hospitals and diagnostic laboratories will pose a challenge to the market growth. The sophistication of these devices also increases maintenance costs for end-users like research laboratories and academic institutes, clinical research organizations, and forensic laboratories that rely heavily on their use for experimentation.
Agilent Technologies, Agilent Technologies, QIAGEN, Roche Diagnostics, Thermo Fisher Scientific, Beckman Coulter, Becton, Dickinson and Company, bioMérieux, Cepheid, Takara Bio, Eppendorf, Fluidigm, GE Healthcare, Harvard Bioscience, Kapa Biosystems, Maxim Biotech, PerkinElmer, Promega, RainDance Technologies, and Siemens Healthcare.